HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypoxic condition induced H3K27me3 modification of the LncRNA Tmem235 promoter thus supporting apoptosis of BMSCs.

Abstract
Bone marrow mesenchymal stem cells (BMSCs) have strong regenerative potential and show good application prospects for treating clinical diseases. However, in the process of BMSC transplantation for treating ischemic and hypoxic diseases, BMSCs have high rates of apoptosis in the hypoxic microenvironment of transplantation, which significantly affects the transplantation efficacy. Our previous studies have confirmed the key role of long non-coding RNA Tmem235 (LncRNA Tmem235) in the process of hypoxia-induced BMSC apoptosis and its downstream regulatory mechanism, but the upstream mechanism by which hypoxia regulates LncRNA Tmem235 expression to induce BMSC apoptosis is still unclear. Under hypoxic conditions, we found that the level of LncRNA Tmem235 promoter histone H3 lysine 27 trimethylation modification (H3K27me3) was significantly increased by CHIP-qPCR. Moreover, H3K27me3 cooperated with LncRNA Tmem235 promoter DNA methylation to inhibit the expression of LncRNA Tmem235 and promote apoptosis of BMSCs. To study the mechanism of hypoxia-induced modification of LncRNA Tmem235 promoter H3K27me3 in the hypoxia model of BMSCs, we detected the expression of H3K27 methylase and histone demethylase and found that only histone methylase enhancer of zeste homolog 2 (EZH2) expression was significantly upregulated. Knockdown of EZH2 significantly decreased the level of H3K27me3 modification in the LncRNA Tmem235 promoter. The EZH2 promoter region contains a hypoxia-responsive element (HRE) that interacts with hypoxia-inducible factor-1alpha (HIF-1α), which is overexpressed under hypoxic conditions, thereby promoting its overexpression. In summary, hypoxia promotes the modification of the LncRNA Tmem235 promoter H3K27me3 through the HIF-1α/EZH2 signaling axis, inhibits the expression of LncRNA Tmem235, and leads to hypoxic apoptosis of BMSCs. Our findings improve the regulatory mechanism of LncRNA Tmem235 during hypoxic apoptosis of BMSCs and provide a more complete theoretical pathway for targeting LncRNA to inhibit hypoxic apoptosis of BMSCs.
AuthorsFei Zhang, Hong Luo, Wuxun Peng, Lei Wang, Tao Wang, Zhihong Xie, Jian Zhang, Wentao Dong, Xiaohan Zheng, Gang Liu, Xuesong Zhu, Qinglin Kang, Xiaobin Tian
JournalApoptosis : an international journal on programmed cell death (Apoptosis) Vol. 27 Issue 9-10 Pg. 762-777 (10 2022) ISSN: 1573-675X [Electronic] Netherlands
PMID35779185 (Publication Type: Journal Article)
Copyright© 2022. The Author(s).
Chemical References
  • Histones
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • RNA, Long Noncoding
  • Histone Demethylases
  • Enhancer of Zeste Homolog 2 Protein
  • Lysine
Topics
  • Apoptosis (genetics)
  • Enhancer of Zeste Homolog 2 Protein (genetics, metabolism)
  • Histone Demethylases (genetics, metabolism)
  • Histones (genetics, metabolism)
  • Humans
  • Hypoxia (genetics, metabolism)
  • Hypoxia-Inducible Factor 1, alpha Subunit (genetics, metabolism)
  • Lysine (genetics, metabolism)
  • Mesenchymal Stem Cells (metabolism)
  • Promoter Regions, Genetic
  • RNA, Long Noncoding (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: